Bayesian inferences and frequentist evaluations

· Source: Statistical Modeling, Causal Inference, and Social Science · Field: Science & Research — Health & Medical Research, Research Methodology & Innovation · Depth: Advanced, quick

Summary

A recent preprint by Martin Forster, Marco Novelli, and Charlie Welch explores the optimal timing for restarting recruitment to a clinical trial disrupted by a pandemic. The authors apply innovations from frequentist and Bayesian decision-theoretic sequential experimental design literature to analyze the "whether" and "when" of resuming trial recruitment. Their work focuses on providing a structured framework to guide decisions in scenarios where external factors, such as a pandemic, interrupt ongoing clinical research. This approach aims to optimize trial efficiency and ethical considerations by determining the most appropriate moment to recommence participant enrollment.

Key takeaway

For clinical trial managers overseeing studies impacted by unforeseen disruptions like pandemics, this research offers a framework to systematically evaluate the decision to restart recruitment. You should consider integrating sequential experimental design principles into your trial management protocols to make data-driven decisions on when and if to resume participant enrollment, optimizing both ethical considerations and resource allocation.

Key insights

Decision-theoretic sequential experimental design can optimize clinical trial recruitment restarts post-pandemic.

Principles

Method

The authors use frequentist and Bayesian decision-theoretic sequential experimental design to model and determine optimal restart points for pandemic-disrupted clinical trials.

In practice

Topics

Best for: AI Scientist, Research Scientist, Data Scientist

Related on AIssential

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Statistical Modeling, Causal Inference, and Social Science.